Skip to main content
Top
Published in:

Open Access 01-12-2017 | Research Article

Nasal Muco-ciliary transport time alteration: efficacy of 18 B Glycyrrhetinic acid

Authors: Desiderio Passali, Chiara Cappello, Giulio Cesare Passali, Cemal Cingi, Codrut Sarafoleanu, Luisa Maria Bellussi

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2017

Login to get access

Abstract

Background

Mucociliary clearance is the main self-clearing system of the nasal cavity and paranasal sinuses.
This is a very important means of non specific defence against continuous organic and inorganic contamination conveyed by air. It works by trapping particles and microorganisms in the mucus and then by transporting the mucous film to the pharynx where it is eliminated with a cough or swallowed. Its congenital or acquired abnormalities are involved in the occurrence of widespread infectious and often severe nose and paranasal sinuses diseases; generally concerning the rhinopharyngealtubal district.
Restoring mucociliary clearance of the nasal epithelium when altered thus represents a key therapeutic tool against rhinosinus chronic diseases.
This study evaluates the clinical efficacy of the inhalation of a natural compound (Narivent® nasal spray) in chronic vasomotor rhinitis.

Methods

The study involved 79 patients suffering from chronic vasomotor rhinitis presenting an increased mucociliary clearance time. Patients were randomized into 2 groups: a first group of 49 subjects and a second group of 30 subjects.
The first group was treated with a nasal spray (Narivent® nasal spray) (2 sprays per nostril twice a day) for 30 days.
The second group was treated with a nasal spray containing isotonic solution in the same way and for the same period of the first group.
Nasal Mucociliary transport time was measured in the patients of both groups before treatment, after 15 days of treatment, and at the end of the 30 days treatment.

Results

The study shows how one of the treatments carried out determines a major objective reduction of the mucociliary clearance time in the patients under examination, using the method which involves the use of an insoluble coloured tracer (vegetable carbon), bringing the values back within normal range. At the end of the study we objectivated an increase in the rate of mucociliary transport in 97.9% percentage of patients we enrolled.

Conclusions

This study shows the effectiveness of treatment with natural extracts with nasal mucosa restoring function in the treatment of chronic vasomotor rhinitis, a nasal inflammatory disease characterized by morphological and functional alteration of the normal nasal mucosa.
Footnotes
1
Narivent® nasal spray
 
Literature
1.
go back to reference Passàli D, Bellussi L, Bianchini Ciampoli M, De Seta E. Experiences in the determination of nasal mucociliary transport time. Acta Otolaryngol. 1984;97(3–4):319–23. Passàli D, Bellussi L, Bianchini Ciampoli M, De Seta E. Experiences in the determination of nasal mucociliary transport time. Acta Otolaryngol. 1984;97(3–4):319–23.
2.
go back to reference Passàli D, Bianchini Ciampoli M. Normal values of mucociliary transport time in young subjects. Int J Pediatr Otorhinolaryngol. 1985;9(2):151–6. Passàli D, Bianchini Ciampoli M. Normal values of mucociliary transport time in young subjects. Int J Pediatr Otorhinolaryngol. 1985;9(2):151–6.
3.
go back to reference Low TH, Woods CM, Ullah S, Carney ASA. Double-blind randomized controlled trial of normal saline, lactated Ringer's, and hypertonic saline nasal irrigation solution after endoscopic sinus surgery. Am J Rhinol Allergy. 2014;28(3):225–31. Low TH, Woods CM, Ullah S, Carney ASA. Double-blind randomized controlled trial of normal saline, lactated Ringer's, and hypertonic saline nasal irrigation solution after endoscopic sinus surgery. Am J Rhinol Allergy. 2014;28(3):225–31.
4.
go back to reference Bercin S, Ural A, Kutluhan A. Effects of topical drops and sprays on mucociliary transport time and nasal air flow. Acta Otolaryngol. 2009;129(11):1257–61. Bercin S, Ural A, Kutluhan A. Effects of topical drops and sprays on mucociliary transport time and nasal air flow. Acta Otolaryngol. 2009;129(11):1257–61.
5.
go back to reference Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis (review). Evid-Based Child Health. 2008;3:459–95.CrossRef Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis (review). Evid-Based Child Health. 2008;3:459–95.CrossRef
6.
go back to reference Kim CH, Hyun Song M, Eun Ahn Y, Lee JG, Yoon JH. Effect of hypo-, iso- and hypertonic saline irrigation on secretory mucins and morphology of cultured human nasal epithelial cells. Acta Otolaryngol. 2005;125(12):1296–300. Kim CH, Hyun Song M, Eun Ahn Y, Lee JG, Yoon JH. Effect of hypo-, iso- and hypertonic saline irrigation on secretory mucins and morphology of cultured human nasal epithelial cells. Acta Otolaryngol. 2005;125(12):1296–300.
7.
go back to reference Bellussi ML, Cocca S, Chen L, Passali FM, Sarafoleanu C, Passali D. Rhinosinusal inflammation and high mobility group box 1 protein: a new target for therapy. ORL J Otorhinolaryngol Relat Spec. 2016;78(2):77–85.CrossRefPubMed Bellussi ML, Cocca S, Chen L, Passali FM, Sarafoleanu C, Passali D. Rhinosinusal inflammation and high mobility group box 1 protein: a new target for therapy. ORL J Otorhinolaryngol Relat Spec. 2016;78(2):77–85.CrossRefPubMed
8.
go back to reference Cavone L, Cuppari C, Manti S, Grasso L, Arrigo T, Calamai L, et al. Increase in the level of Proinflammatory cytokine HMGB1 in nasal fluids of patients with rhinitis and its sequestration by glycyrrhizin induces eosinophil cell death. Clin Exp Otorhinolaryngol. 2015;8(2):123–8. Cavone L, Cuppari C, Manti S, Grasso L, Arrigo T, Calamai L, et al. Increase in the level of Proinflammatory cytokine HMGB1 in nasal fluids of patients with rhinitis and its sequestration by glycyrrhizin induces eosinophil cell death. Clin Exp Otorhinolaryngol. 2015;8(2):123–8.
9.
go back to reference Chen D, Mao M, Bellussi LM, Passali D, Chen L. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2014;4(6):453–62. Chen D, Mao M, Bellussi LM, Passali D, Chen L. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2014;4(6):453–62.
10.
go back to reference Chen D, Bellussi LM, Passali D, Chen L. LPS may enhance expression and release of HMGB1 in human nasal epithelial cells in vitro. Acta Otorhinolaryngol Ital. 2013;33(6):398–404. Chen D, Bellussi LM, Passali D, Chen L. LPS may enhance expression and release of HMGB1 in human nasal epithelial cells in vitro. Acta Otorhinolaryngol Ital. 2013;33(6):398–404.
11.
go back to reference Bellussi LM, Iosif C, Sarafoleanu C, Jianu E, Duda R, Panaitescu E, Passali FM, Passali D. Are HMGB1 protein expression and secretion markers of upper airways inflammatory diseases? J Biol Regul Homeost Agents. 2013;27(3):791–804. Bellussi LM, Iosif C, Sarafoleanu C, Jianu E, Duda R, Panaitescu E, Passali FM, Passali D. Are HMGB1 protein expression and secretion markers of upper airways inflammatory diseases? J Biol Regul Homeost Agents. 2013;27(3):791–804.
12.
go back to reference Bellussi LM, Chen L, Chen D, Passali FM, Passali D. The role of high mobility group box 1 chromosomal protein in the pathogenesis of chronic sinusitis and nasal polyposis. Acta Otorhinolaryngol Ital. 2012;32(6):386–92. Bellussi LM, Chen L, Chen D, Passali FM, Passali D. The role of high mobility group box 1 chromosomal protein in the pathogenesis of chronic sinusitis and nasal polyposis. Acta Otorhinolaryngol Ital. 2012;32(6):386–92.
13.
go back to reference Passali D, Kern E, Lei Chen R, Bellussi L. High mobility group box 1 (HMGB 1): a new protein in the pathogenesis of ENT inflammatory and infectious diseases. Acta Otorhinolaryngol Ital. 2012;32(1):46–7. Passali D, Kern E, Lei Chen R, Bellussi L. High mobility group box 1 (HMGB 1): a new protein in the pathogenesis of ENT inflammatory and infectious diseases. Acta Otorhinolaryngol Ital. 2012;32(1):46–7.
14.
go back to reference Bellussi LM, Cocca S, Passali GC, Passali D. HMGB1 in the Pathogenesis of Nasal Inflammatory Diseases and its Inhibition as New Therapeutic Approach: A Review from the Literature. Int Arch Otorhinolaryngol. 2017;01:1–108. Bellussi LM, Cocca S, Passali GC, Passali D. HMGB1 in the Pathogenesis of Nasal Inflammatory Diseases and its Inhibition as New Therapeutic Approach: A Review from the Literature. Int Arch Otorhinolaryngol. 2017;01:1–108.
15.
go back to reference Chen D, Bellussi LM, Cocca S, Wang J, Passali GC, Hao X, et al. Glycyrrhetinic acid suppressed HMGB1 release by up-regulation of Sirt6 in nasal inflammation. J Biol Regul Homeost Agents. 2017;31(2):269-77. Chen D, Bellussi LM, Cocca S, Wang J, Passali GC, Hao X, et al. Glycyrrhetinic acid suppressed HMGB1 release by up-regulation of Sirt6 in nasal inflammation. J Biol Regul Homeost Agents. 2017;31(2):269-77.
16.
go back to reference Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. An antinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:861–70.CrossRefPubMedPubMedCentral Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. An antinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:861–70.CrossRefPubMedPubMedCentral
17.
go back to reference Hwang JS, Lee WJ, Kang ES, Ham SA, Yoo T, Paek KS, et al. Ligand-activated peroxisome proliferator-activated receptor-δ and –γ inhibit lipopolysaccharide-primed release of high mobility group box 1 trough upregulation of SIRT1. Cell Death Dis. 2014;5:e1432. Hwang JS, Lee WJ, Kang ES, Ham SA, Yoo T, Paek KS, et al. Ligand-activated peroxisome proliferator-activated receptor-δ and –γ inhibit lipopolysaccharide-primed release of high mobility group box 1 trough upregulation of SIRT1. Cell Death Dis. 2014;5:e1432.
Metadata
Title
Nasal Muco-ciliary transport time alteration: efficacy of 18 B Glycyrrhetinic acid
Authors
Desiderio Passali
Chiara Cappello
Giulio Cesare Passali
Cemal Cingi
Codrut Sarafoleanu
Luisa Maria Bellussi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Multidisciplinary Respiratory Medicine / Issue 1/2017
Electronic ISSN: 2049-6958
DOI
https://doi.org/10.1186/s40248-017-0110-7

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more